|
Post by tw12 on Mar 29, 2017 15:05:53 GMT -5
It was a small office, devoted only to dermatology. The screen was on the wall, in the examination room, directly in front of the examination table. A patient could not miss it. And the half-dozen miscellaneous ads all ran without sound.
|
|
|
Post by dreamboatcruise on Mar 29, 2017 17:04:36 GMT -5
It was a small office, devoted only to dermatology. The screen was on the wall, in the examination room, directly in front of the examination table. A patient could not miss it. And the half-dozen miscellaneous ads all ran without sound. Did it appear to be infographic type of ad that wasn't meant to have sound? In isolation would it convince you Afrezza is something different and useful? I haven't yet seen these types of screens in a doctor's office, so not familiar with the format. It's interesting, ContextMedia (now Outcome Health) doesn't yet list Mannkind as a client on their website.
|
|
|
Post by tw12 on Mar 29, 2017 20:47:40 GMT -5
Yes, it was a "complete" ad, easy to read, nicely presented, not intended to have sound. Featured "outsulin" ready to sprint.
If someone can clue me in on exactly how to post a photo here, I would be happy to include the one I took...
|
|
|
Post by mnkdfann on Mar 29, 2017 21:05:40 GMT -5
Didn't the last conference call have a slide of two of a typical office set-up offering ContextMedia:Health? That's what I recall. BTW, Context Health renamed itself Outcome Health in January of this year. You can see typical office set ups / devices on its web page: www.outcomehealth.com/products/
|
|
|
Post by liane on Mar 30, 2017 6:12:47 GMT -5
Yes, it was a "complete" ad, easy to read, nicely presented, not intended to have sound. Featured "outsulin" ready to sprint. If someone can clue me in on exactly how to post a photo here, I would be happy to include the one I took... Use the full reply mode (not "quick reply"). Then use the "Add Attachment" button (upper right). Must be < 1MB. Also, I think you have to do this from computer (not smart phone) - but I may be wrong on this.
|
|
|
Post by kbrion77 on Mar 30, 2017 6:44:15 GMT -5
Down to 1.47 pre-market. .29 pre-split folks.
|
|
|
Post by boca1girl on Mar 30, 2017 7:49:39 GMT -5
If a 50% decline from the RS is common place, $1.25 is in the cards. The upgrade from hold to buy by Thomas Reuters on March 27 did nothing to stop this downward spiral.
On March 27, 2017 Thomson Reuters/Verus upgraded MANNKIND CORPORATION ( MNKD ) from HOLD to BUY.
The last few days it seems that every long term holder was throwing in the towel. Maybe that is the sign of capitulation.
|
|
|
Post by mnkdfann on Mar 30, 2017 9:45:42 GMT -5
The last few days it seems that every long term holder was throwing in the towel. Maybe that is the sign of capitulation. I don't think so. Capitulation would be Kastanes selling.
|
|
|
Post by peppy on Mar 30, 2017 12:36:00 GMT -5
Yes, it was a "complete" ad, easy to read, nicely presented, not intended to have sound. Featured "outsulin" ready to sprint. If someone can clue me in on exactly how to post a photo here, I would be happy to include the one I took... I first saw one of these screens in a physicians waiting room years ago. not sure they were running medication commercials, maybe, blood pressure and exercise prevention included? I can see the business model. An ad just prior to stepping into the physicians office.
You tube is running full medication advertisements (not afrezza) as well prior to staring the youtube presentation. A prefect format for Afrezza, it is young. We need insurance coverage and a lower price for the titration pack for 18 year old plus wouldn't hurt.
|
|
|
Post by harryx1 on Mar 30, 2017 16:43:16 GMT -5
Naked shorting continues to run rampant... 65.23% of shares sold short today were Naked. 54% of the volume today was shares sold short.
|
|
|
Post by agedhippie on Mar 30, 2017 16:45:36 GMT -5
Naked shorting continues to run rampant... 65.23% of shares sold short today were Naked. 54% of the volume today was shares sold short. Where is that from? It looks like a useful site.
|
|
|
Post by mnkdfann on Mar 30, 2017 16:48:31 GMT -5
|
|
|
Post by harryx1 on Mar 30, 2017 16:49:19 GMT -5
|
|
|
Post by mnkdfann on Mar 30, 2017 16:54:18 GMT -5
Then I stand corrected.
|
|
|
Post by dreamboatcruise on Mar 30, 2017 17:06:20 GMT -5
It does seem to be the short data reported on FINRA... but that data on FINRA is total shorted, correct? Does not have anything to do with fail to deliver. What does that other site mean by "naked shorting". That is the part that seems misleading to me. My understanding is that "naked shorting" generally means shorting when one has not already borrowed or at least legitimately verified that shares can be borrowed in time for delivery. Using that meaning the graph is misrepresenting short volume for naked short volume.
|
|